We are live on
!
Find out more
TM
Tikvah Management Portfolio holdings
AUM
$323M
1-Year Est. Return
69.61%
This Fund
S&P 500
This Quarter
Est. Return
-8.7%
1 Year Est. Return
+69.61%
3 Year Est. Return
+173.03%
5 Year Est. Return
+103.33%
10 Year Est. Return
+586.01%
AUM
$359M
AUM Growth
-$11.3M
(-3%)
Cap. Flow
+$10M
Cap. Flow
% of AUM
2.79%
Top 10 Holdings %
Top 10 Hldgs %
86.11%
Holding
25
New
4
Increased
3
Reduced
1
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVDX
AvidXchange
AVDX
|
+$47.1M |
| 2 |
WEJO
Wejo Group Limited Common Shares
WEJO
|
+$16.4M |
| 3 |
ATYR
aTyr Pharma
ATYR
|
+$10.2M |
| 4 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
+$4.87M |
| 5 |
Nautilus Biotechnolgy
NAUT
|
+$2.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
+$46.8M |
| 2 |
QADA
QAD Inc.
QADA
|
+$16M |
| 3 |
QADB
QAD Inc. Class B
QADB
|
+$7.49M |
| 4 |
VOSOW
Virtuoso Acquisition Corp. Warrant
VOSOW
|
+$2M |
| 5 |
Bio-Rad Laboratories Class B
BIO.B
|
+$1,000K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.33% |
| 2 | Technology | 18.95% |
| 3 | Consumer Discretionary | 17.46% |
| 4 | Communication Services | 14.9% |
| 5 | Consumer Staples | 1.09% |
Similar funds
GIM
CRI
BCP
UOC
BEP
AIA
FAL
AC
Tikvah Management's Q4 2021 Portfolio in Review
As of Q4 2021, Tikvah Management held 25 positions worth $359M, down 3% from $370M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Tikvah Management's Q4 2021 filing shows 4 new, 3 increased, 1 reduced and 4 closed positions. Its largest new stake was AvidXchange: 2,256,518 shares worth $34M. The largest sale was Inovalon Holdings, Inc. Class A Common Stock, an estimated $46.8M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
- Tikvah Management's largest Q4 2021 buy was AvidXchange: 2,256,518 shares worth $34M.
- Tikvah Management added most to SomaLogic, Inc. Class A Common Stock in Q4 2021, an estimated $4.87M increase.
- Tikvah Management's biggest Q4 2021 reduction was Bio-Rad Laboratories Class B, cutting an estimated $1,000K.
- Tikvah Management fully exited Inovalon Holdings, Inc. Class A Common Stock in Q4 2021, selling an estimated $46.8M.
- Tikvah Management's ten largest holdings make up 86% of its $359M portfolio in Q4 2021.
- Tikvah Management opened 4 new positions and closed 4 in Q4 2021.
- Tikvah Management's portfolio value fell 3% quarter-over-quarter to $359M.
Based on Tikvah Management's 13F filing for Q4 2021, filed 14 Feb 2022.